chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe leg and hip pain; Severe leg and hip pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration on 22Jan2021 09:00 (at the age of 57years) at single dose for Covid-19 immunization. Medical history included migraine. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included ibuprofen (ADVIL), levothyroxine sodium (SYNTHROID), amitriptyline, rizatriptan benzoate (MAXALT), and butalbital, caffeine, paracetamol (FIORICET); all taken from an unspecified date for an unspecified indication. The patient previously took compazine and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Jan2021 06:00, the patient experienced severe leg and hip pain. There was no treatment received for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The outcome of events was not recovered. This case is non-serious.
Patient was given a Tdap on 1/23/2020.  He was given a Tdap on 6/25/2020 by mistake.  Patient has been notified.  He is not feeling any adverse effects to this vaccine.
Aching muscles all over (like with severe flu) Severe migraine headache--sensitive to light, noise, movement--causing vomiting Dizziness/lightheaded Dr. recommended alternate use of Tylenol and Advil and prescribed anti nausea medication. 3 days of reaction.  Am still lightheaded and dizzy.
Dizziness and nausea. Took dramamine the night of and generic meclizine the other 2 days. Metallic taste, buy specifically where I have had a filling for 6 years. Red blotchy rash around injection site.
This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients were administered with Moderna COVID-19 Vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 11-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 3-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 vaccination. No Medical History information was reported. On 11-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 11-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients were administered with Moderna COVID-19 Vaccine after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 11-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients were administered with Moderna COVID-19 Vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 11-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patients were administered with Moderna COVID-19 Vaccine after 30-day use by date) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 11-Aug-2022). No concomitant product use was reported. The number of doses/vials around 50 doses from 5 vials. On 08-Jul-2022 the vials were initially stored in the refrigerator. The vaccines were administered from the 07-Aug-2022 until the 11-Aug-2022. Vial did not undergone any temperature excursions. The healthcare professional was not aware of any symptoms for any patient after the vaccine was given. No treatment information was provided.
Pt had a quarter size welt on his left thigh. Mom said noticed it 5-16-17 when he woke up. The area is warm to the touch.
Took shot at 9:30 a.m. At 4:30 p.m. severe chills and shaking. Next morning when I got out of bed I became very nauseated and began to perspire at which point I fainted.
A severe headache, vomiting, injection site was swollen, red and sore, glands under my left arm were swollen, and pain radiated into my back under my scapula. I still continue to have back pain on that side.
Parent reporting that arm that MMR vaccine administeed in, is red approximately 2 x 4" around injection site with a wheal approximately 1" in diameter.?Tender to touch.
Soon after Imms given urticarial rash over neck area only. No progression noted, on observation for 15 min. BENADRYL 4ml given. Clear chest, no distress, no fever on exam before child left the office. Advised Mom to call us at the clinic if rash progresses or still concerned. An oncall Dr. would call her back. RN called Mom at 5:30pm, rash all gone, didn't repeat BENADRYL at home.
Immediate pain at site of injection. Pain got worse overnight and continued. Swelling at injection site lasted over 10 days.
pt recvd vax & 2 mins later pt began to slide off table; eyeballs rolled back & began jerking; MD called in; vs taken; pt observed;
My daughter was told by a nurse to sit for 2-3 minutes after the injection of Gardasil. My daughter did this, slowly stood upright to make sure she felt alright after 3 minutes. She felt fine, stood by exam table for another 2 minutes and then we proceeded to check out at desk. We headed for the exit door of the pediatricians office, my daughter stopped walking, said she didn't feel right, felt very dizzy, her eyes rolled up into the back of her head several times, her head was wobbling (like she couldn't support it), her legs were like rubberbands and she started collapsing in my boyfriends arms. He layed her down on the office floor. My daughter was completely passed out, sweating, and her legs and arms were jerking and twitching like she was having a seizure!! I immediately got the nurse who administered the shot, and they took her blood pressure and said it was very low and I asked for cold compresses for her head. This all happened within 10-15 minutes after the vaccination of Gardasil!!
within <24 hours of injection, patient began to experience aches in major joints with minor swelling, localized fever to the joints, stiffness, and difficulty with movement. the pain, swelling, and fever in joints continued over a period of months post injection, and lead to myalgia in the upper back, shoulders, arms, and legs. By May/June of 2010 patient was diagnosed with fibromyalgia by her primary care physician
Rash mild, non-pruritic rash to left leg and some on right leg began today 1/29/21, 4 days post 2nd dose Pt reported via phone today that she received her 2nd vaccine injection four days ago with no untoward effects until today. She noticed a rash appearing on her left leg, with some involvement of her right leg. Denies sob, urticaria, pruritis, swelling, erythema or bullous nature of rash. Denies sensations of swelling or tingling of the mouth, throat, lips or pain anywhere. She reports she is at work today and called seeking guidance for rash treatment. She reports taking OTC ceterizine daily in the am for seasonal allergies, and famotadine nightly for same. We discussed adding OTC oral diphenhydramine to trial effect on rash, however she reports previous tachycardia with oral diphenhydramine and isn't comfortable trying this. We discussed OTC topical diphenhydramine cream as well as OTC topical cortisone cream for rash treatment. Lastly we discussed when to seen emergent or urgent care, i.e., those that are life threatening & possible anaphylactic in nature, such as the sensation of swelling or tingling of mouth, lips, or throat, tachycardia not r/t activity, new onset of significant weakness or dizziness or syncope. Advised to contact employee health and her supervisor if she needs to be evaluated in the ED while at work, otherwise to contact her PCP. She states she understands her options.
At 1800 on 3/3/2015 I felt pain in left armpit. Looked in mirror 2 red streaks outer aspect of left arm where shot given going into armpit. Armpit completely swollen - pink and painful. Dr. closed. Put warm pack on for 20 minutes took it off looked entire left side of body pink. Abdomen pink expanded from armpit all the way down left side after warm pack - even outlining my ribs on left side to belly button. Next day saw Dr at 10:15 am he felt it was infection. Dr prescribed cefadroxil 500mg capsule 2 x's a day x's 7 days. Redness all gone on 3/7/2015 at 700.
Severe eye pain with eye twitching. generalized body aches and fatigue. pain swelling redness and warmth at injection site.
My hair started falling out. It's gotten worse in last month, or so.; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (My hair started falling out. It's gotten worse in last month, or so.) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 071F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced ALOPECIA (My hair started falling out. It's gotten worse in last month, or so.). At the time of the report, ALOPECIA (My hair started falling out. It's gotten worse in last month, or so.) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-395776, MOD-2021-395763, MOD-2021-395825 (Patient Link).
Patient reported following PNEUMOVAX vaccine, she went home & cleaned her house. That evening, she started having chills and she was unable to move left arm. She applied heat and took ASA 2 tabs. Examined 4/29/11 and skin on (L) deltoid without edema, erythema, or warmth, decreased ROM. Instructed use ice and gave TYLENOL with codeine Elixir.
Patient had fillers put in her cheeks by dermatologist last Summer and her pain and swelling is exactly at the site of the fillers.
Pt. reported feeling dizzy, nauseous, light headed and tingling all over body. 15 minutes after vaccine - still feeling same. 1 hour later - taken to ED for evaluation. Dx: Adverse drug reaction and D/C stable.
I had sudden onset severe lower abdominal pain starting 8 hours after my second dose of the Moderna vaccine and it lasted 5 hours without any relief despite being medicated with narcotics.
She has had pneumonia; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age (reported as Age: 75; Unit: Unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration second dose on an unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on an unspecified date for Covid-19 immunization. It was reported that patient has had pneumonia. The reporter stated that completing the vaccine was emotional relief. You feel like now you probably won't get sick and if you do you have a real low chance of hospitalization and if you do get hospitalized there is a miniscule chance of dying. It was like having a weight lifted off the shoulder as they say. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Severe ear and eye pain; Severe ear and eye pain; This is a spontaneous report received from a contactable nurse. A 51-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), intramuscular in left arm, on 21Dec2020 15:15, at single dose, for COVID-19 immunization. Medical history included hypertension, depression, and known allergies to eggs, latex, nuts and codeine. The patient is not pregnant. Concomitant medication included aspirin (ASPIRIN), ascorbic acid (VITAMIN-C), hydrochlorothiazide, lisinopril (ZESTORETIC), venlafaxine and zinc. The patient previously took codeine and experienced allergy. The patient experienced severe ear and eye pain on 21Dec2020 at 18:30. It was also reported that the patient did not receive any vaccines within 4 weeks prior to BNT162B2. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since vaccination. Treatment included ibuprofen and rest. The outcome of the events was recovering.  Information on the Batch/Lot number has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 81-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "IPF (Idiopathic Pulmonary Fibrosis)" (unspecified if ongoing), notes: Other medical history: IPF (Idiopathic Pulmonary Fibrosis), heart disease; "heart disease" (unspecified if ongoing), notes: Other medical history: IPF (Idiopathic Pulmonary Fibrosis), heart disease; "Known allergies: Sulphur" (unspecified if ongoing), notes: Known allergies: Sulphur. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures included Paxlovid from  02Aug2023 to 06Aug2023 were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever over 100.4, chills, headache, dizziness Treatment- rest and fluids Time-2 days
8/26/21 presents to urgent care requesting COVID-19 testing due to experiencing COVID-19 symptoms and exposure to COVID-19 8/27/21 PMH of CAD s/p PCI, HTN, Hyperlipidemia, COPD, Tobacco Abuse, Obesity and RA who presented to ER with c/o SOB and difficulty with speech
24 hours, post vax, pt had red, swelling and warm right arm, 8cm X 13cm.
Info has been received from a physician concerning a 15 month old healthy male with no medical history or allergies who in 11/05, was vaccinated with a dose of MMRII. Concomitant vaccinations on that same day included a dose of DT (unspecified (+) tetanus toxoid. The physician reported that in 12/05, 2 days, post/vax, the pt developed severe diffuse swelling in his leg. Unspecified medical attention was sought. No treatment or lab or diagnostic tests was required. At the time of this report, the pt was recovering from the severe diffuse swelling in his leg. Additional info has been requested.
Expired within 30days of vaccination.  Received vaccine 1/22/21 did not have any complaints, during a bed check she was found on the floor with no apparent injury, no pulse or respirations.
Information has been received from a registered nurse concerning a patient who was vaccinated SC with a 0.65ml dose of ZOSTAVAX at the lower arm. On an unspecified date, the patient developed mild shingles. Subsequently, the patient recovered from shingles. No lab tests were performed. The patient was seen in the office and sought unspecified medical attention. This is one of several reports received from the same source. Additional information has been requested.
positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable other health care professional. A 62-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), 1st dose (lot number EL3248) on Jan2021 05:45, 2nd dose (lot number EL3248, as reported) on 04Feb2021 06:00, both at 61-year-old intramuscular in left arm for Covid-19 immunization. Medical history was not provided. There was no other medications in two weeks. There was no other vaccine in four weeks. It was unknown if patient had covid prior vaccination. There was no known allergies. Patient experienced symptoms of covid starting on 01Aug2021, and was tested positive for covid PCR Nasal swab on 05Aug2021. Treatment was unknown. Outcome of the event was not resolved.; Sender's Comments: The possibility of Covid19,  being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.
Initial pain in Shoulders and Neck (Bilateral) Descending Peripheral Bilateral Neuropathy  in legs and Feet on Wednesday , Followed by Ataxia  Tremors in 5 th digit of both hands , Itching on both wrists up to elbows bilaterally Numbness appears to have resolved. Numbness persists on left abdomen from waist to underarm. Thursday and then Friday then stronger in legs . Saturday weaker in legs , lack of balance with  some word retrieval relative to previous days.
The day after the vaccine I was very wiped out tired; tenderness, redness, and swelling at the injection site; tenderness, redness, and swelling at the injection site; tenderness, redness, and swelling at the injection site; I could barely function; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (I could barely function), FATIGUE (The day after the vaccine I was very wiped out tired), INJECTION SITE PAIN (tenderness, redness, and swelling at the injection site), INJECTION SITE ERYTHEMA (tenderness, redness, and swelling at the injection site) and INJECTION SITE SWELLING (tenderness, redness, and swelling at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005M21A) for COVID-19 prophylaxis.     Patient didn't received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: Pfizer (1 st dose), Pfizer (first booster dose) and Pfizer (2nd dose). Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer.    On 22-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2022, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (I could barely function). On 23-Apr-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (The day after the vaccine I was very wiped out tired), INJECTION SITE PAIN (tenderness, redness, and swelling at the injection site), INJECTION SITE ERYTHEMA (tenderness, redness, and swelling at the injection site) and INJECTION SITE SWELLING (tenderness, redness, and swelling at the injection site). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (I could barely function), FATIGUE (The day after the vaccine I was very wiped out tired), INJECTION SITE PAIN (tenderness, redness, and swelling at the injection site), INJECTION SITE ERYTHEMA (tenderness, redness, and swelling at the injection site) and INJECTION SITE SWELLING (tenderness, redness, and swelling at the injection site) outcome was unknown.            No concomitant medication was reported. It was reported that the patient had more of a reaction than she did to Pfizer. No treatment information was provided.   This case was linked to MOD-2023-748680, MOD-2023-748686, MOD-2023-748684 (Patient Link).
shingles; This is a spontaneous report from a contactable consumer (patient).   A 75-year-old female patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Left Arm on 18Feb2021 11:35, at the age of 75-years-old, (Lot Number: EN6201) as 1st dose, single for covid-19 immunisation.  Medical history included none.   The patient's concomitant medications was none. The patient was supposed to get her second vaccine but got shingles on 06Mar2021, after first dose and was told she can't get the second vaccine because of the shingles. The outcome of the event was not recovered.
Patient had fever and was given TYLENOL at 1am on 10/29/14. At 4am mother noticed child had vomited and was again running fever. Patient was taken to local ED with rectal temp of 40.8 at 4:28am. Treated with 100mg ibuprofen and 2mg ondansetron and sent home with instructions to alternate TYLENOL and MOTRIN every 3 hours. Child was not given any medication after discharge and arrived at our clinic at 9:45 with fever of 105.5. Given 80mg ibuprofen and covered with ice packs and wet towels to reduce fever. EMS was called when child's fever 15 minutes later was 106.4. At time of EMS arrival 16 minutes later temperature had dropped to 104.9. Child is currently being evaluated at the hospital.
74-year-old female with reported history of diabetes brought in to Hospital by EMS status post cardiac arrest. Per EMS she was driving to urgent care for unknown reason. She just got her 2nd pfizer vaccine somewhere. She collapsed at Urgent Care and CPR was initiated immediately. EMS arrived and her initial rhythm was PEA. They placed an igel and administered 3 rounds of CPR with 3 onset epinephrine. No shockable rhythm. Patient arrives intubated and unresponsive. Patient was transferred to different hospital.
No further information is available; a patient inadvertently received the second dose of PNEUMOVAX23; This spontaneous report was received from an office manager, referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were not provided.     On 26-JUN-2018, the patient was given the first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, route, lot # and expiration date were unknown) for prophylaxis.  On 17-MAY-2021, the patient inadvertently received the second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (1 dose, lot # T033369 and expiration date 26-MAY-2022; strength and route were unknown) for prophylaxis (inappropriate schedule of product administration). No pqc. No further information was available. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T033369; expirationdate: 26-MAY-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
Syncope followed by ER visit determined Left Bundle Branch Block Cardiology follow up - Holter Monitor, Stress Test and Echo - Low Normal EF 50% Cath Lab visit - Clean Cardiac MRI - Low EF Left side weakness
Patient reports that she had facial swelling and some tongue swelling.  She took Benadryl and it was helpful.
A lot of headache and brain pain, thigh pain, fever, fatigue in my eyes.
Started with signs of chicken pox 8 days after vaccine over entire back, neck, front, abdomen. No comitant symptoms no fever, no stomach symptoms, no pain, no cough, no runny nose, no sore throat. Positive puritis.
headache, cough, shortness of breath, body aches, ear pain, sinus congestion, nasal congestion, post nasal drainage starting on 9/7/21
Narrative: Prolonged hospitalization (8/22-9/13) for acute hypoxic respiratory failure due to COVID-19 in fully vaccinated patient. Multiple co-morbidities as outlined in report. Secondary diagnoses on discharge include: septic shock, possible superimposed bacterial pneumonia, acute tubular necrosis on CKD stage III, hyperkalemia, complicated UTI and pulmonary hypertension. Received dexamethasone and supplemental oxygen (including times of HHF 50L 70%) for COVID. Also received antibiotics, hyperkalemia treatments, temporary HD, levophed. Discharged to home. Hypoxia improved but not resolved. Requiring 2L NC oxygen with exertion at discharge.